http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0118224-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_15d42f684941d5b0617ca7764ebdff07
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-42
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-861
filingDate 2000-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c0a327f2317a3d1adf526859622eda9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5d7636a7d6756d3d4ed297cc4a9d7f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6572beff9b665c93041def893d84c331
publicationDate 2001-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0118224-A1
titleOfInvention Adenoviral vectors modified for increased and persistent expression of the cystic fibrosis transmembrane conductance regulator gene in human airway epithelia
abstract Disclosed are recombinant viral vectors for gene transfer to the epithelium of patients. Preferred embodiments include adenoviral vectors designed for the efficient transfer of the DNA encoding the cystic fibrosis transmembrane conductance regulator (CFTR) to human airways in vivo. The present invention provides vectors for the enhanced expression and persistence of a gene such as CFTR, which may allow lower vector doses and/or longer intervals between readministration and which comprise, in operable linkage, the keratin 18 (K18) promoter/enhanier element, an intron, the transgene and a stability enhancing element.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0206502-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0206502-A2
priorityDate 1999-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9709441-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9936545-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10690
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65070
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394037
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415114
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129733198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID47936
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393853
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6076
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396823
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399282
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25322948
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127866646
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16231
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128566414

Total number of triples: 48.